LOUISVILLE, Ky., Oct. 7, 2025 /PRNewswire/ — RAAPID Inc., a leader in AI-powered risk adjustment solutions, today announced it has achieved the prestigious Microsoft Healthcare AI Certified Software designation. This certification validates RAAPID’s Neuro-Symbolic AI platform as meeting Microsoft’s rigorous standards for clinical relevance, data privacy, and responsible AI in healthcare.
The certification strengthens RAAPID’s position as the trusted partner for health plans facing intensified CMS RADV audits and the transformation to value-based care. RAAPID’s solutions, available through Azure Marketplace, deliver defensible accuracy with transparent, explainable AI that links every HCC to evidence-based clinical documentation.
“This Microsoft certification recognizes our commitment to delivering secure, trusted, and clinically impactful AI solutions for healthcare,” said Chetan Parikh, CEO of RAAPID. “Our Neuro-Symbolic AI technology empowers payers and providers with intelligent automation tools that transform risk adjustment from chaos to control, achieving 60-80% productivity gains while ensuring complete data sovereignty within their Azure environment.”
RAAPID’s Novel Clinical AI Platform
addresses critical industry challenges through three flagship solutions: the RADV Audit Solution, which transforms high-stakes audits into predictable processes; the Retrospective Risk Adjustment Solution, which creates a single source of truth for member risk; and the Prospective Risk Adjustment Solution, which enables proactive care gap closure at the point of care. All solutions are deployed within customers’ Azure tenants, ensuring that PHI never leaves their infrastructure.
Healthcare organizations using RAAPID report 5x+ return on investment, with $2,000-$4,000 additional revenue captured per member and 98%+ coding accuracy. The Microsoft certification further validates RAAPID’s enterprise-grade security, HITRUST certification, and seamless integration capabilities with Azure.
About RAAPID
RAAPID develops AI-powered risk adjustment solutions for healthcare payers, providers, and supporting organizations. The company’s HITRUST-certified platform uses Neuro-Symbolic AI to identify chronic conditions, determine HCC codes, and provide explainable documentation for complete audit defense. Backed by M12 (Microsoft’s venture fund), RAAPID serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs with both retrospective and prospective risk capture capabilities. Founded by healthcare technology veterans with over 20 years of experience, RAAPID is headquartered in Louisville, Kentucky.
Learn more at www.raapidinc.com.
Contact
Mayur Vyas
Director – Marketing
(502) 699-3044
402302@email4pr.com
SOURCE RAAPID INC
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…